Hengrui Therapeutics' Series A Round

Hengrui Therapeutics raised a round of funding on June 23, 2016. Investors include HR Bio Holdings.

Hengrui Therapeutics is a recently formed biopharmaceutical company engaged in the development and commercialization of innovative cancer therapies. The company's drug pipeline consists of multiple cl…

Articles about Hengrui Therapeutics' Series A Round: